Gilead can make enough remdesivir to treat ‘several million’ next year

Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings.   ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more

Gilead CEO promises to make remdesivir affordable

The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it.  ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more

FDA has APPROVED experimental drug Remdesivir for emergency use for coronavirus patients

President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients.  ‘I’m pleased to announce that Gilead now has an E wave from the FDA for remdesivir,’ Trump said.  It is the first drug shown to help fight the disease, which has killed more than 64,000 … Read more

FDA has APPROVED experimental drug Remdesivir for emergency use for coronavirus patients

President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients.  It is the first drug shown to help fight the disease, which has killed more than 64,000 people in the United States.  Gilead’s chief executive officer Daniel O’Day, whose company produces remdesivir joined President Trump, … Read more

Remdesivir trial data ‘offers hope,’ says Gilead CEO

On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News.   ‘Positive data’ from … Read more

Is remdesivir REALLY a coronavirus wonder drug? Doubts after another study finds no benefit

Doubts have been cast over the promising COVID-19 drug remdesivir that has shown ‘fantastic results’, after another study found it had no benefit. Remdesivir was reported by US officials to have ‘clear-cut’ evidence that it can help people recover from COVID-19, shortening the time of recovery. Dr Anthony Fauci, America’s top infectious disease expert, said … Read more

US may approve emergency use of Ebola drug remdesivir TODAY

The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more

US may approve emergency use of Ebola drug remdesivir TODAY

The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more

FDA may approve emergency use authorization of Ebola drug remdesivir TODAY

The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more

FDA may approve emergency use authorization of Ebola drug remdesivir TODAY

The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more